Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunomodulation in autoimmune diseases.

P Gergely1, I Láng, R Gonzalez-Cabello

  • 1Second Department of Medicine, Semmelweis University, Budapest, Hungary.

The Tokai Journal of Experimental and Clinical Medicine
|January 1, 1986
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Der Nervenarzt·2025
Same author

Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)].

ESMO open·2024
Same author

[Relapse prevention of bipolar disorders: a cluster analytical approach in a randomized controlled psychotherapy study].

Der Nervenarzt·2024
Same author

Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00.

European journal of cancer (Oxford, England : 1990)·2024
Same author

Genomic characterisation of hormone receptor-positive breast cancer arising in very young women.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same journal

Dengue Fever Complicated by Acute Acalculous Cholecystitis and Hemophagocytic Lymphohistiocytosis Despite Negative PCR.

The Tokai journal of experimental and clinical medicine·2026
Same journal

Carbamazepine-Induced Drug-Induced Hypersensitivity Syndrome With Primary Adrenal Insufficiency: A Case Report.

The Tokai journal of experimental and clinical medicine·2026
Same journal

Electrocautery-Assisted Pleural Puncture for a Highly Reproducible Rat Pneumothorax Model.

The Tokai journal of experimental and clinical medicine·2026
Same journal

Effect of a Reduced Frame Rate for Videofluoroscopic Swallowing Studies on the Recognition of Aspiration in Adult Patients.

The Tokai journal of experimental and clinical medicine·2026
Same journal

Successful Engraftment After Repeat Cord Blood Transplantation Using an Identical Conditioning Regimen for MPS II.

The Tokai journal of experimental and clinical medicine·2026
Same journal

Accuracy of Kampo Diagnostic Support System: Comparison With Certified Physicians of the Japan Society for Oriental Medicine.

The Tokai journal of experimental and clinical medicine·2026
See all related articles

This study investigated immunomodulatory agents for autoimmune diseases. Glutaurine and ketoconazole showed limited clinical efficacy, while gutimine and its derivative demonstrated in vitro immunostimulatory effects requiring further in vivo validation.

Area of Science:

  • Immunology
  • Pharmacology
  • Autoimmune Diseases

Background:

  • Systemic autoimmune diseases are typically managed with immunosuppressive drugs.
  • Immunomodulatory agents offer potential therapeutic benefits for specific autoimmune disorders.

Purpose of the Study:

  • To evaluate the in vitro and in vivo effects of glutaurine, ketoconazole, gutimine, and its derivative (T 001) on immune responses.
  • To assess the potential of these agents in treating autoimmune conditions.

Main Methods:

  • In vitro and in vivo experiments were conducted to assess the immunomodulatory and immunostimulatory activities of the agents.
  • Clinical course of systemic lupus erythematosus was monitored in relation to glutaurine treatment.

Main Results:

Related Experiment Videos

  • Glutaurine exhibited moderate immunostimulating activity but did not alter the clinical progression of systemic lupus erythematosus.
  • Ketoconazole suppressed immune responses in vitro but had no effect on in vivo cellular reactivity in patients.
  • Gutimine and its derivative (T 001) displayed in vitro immunostimulatory activity.

Conclusions:

  • Glutaurine and ketoconazole demonstrate limited therapeutic potential for systemic autoimmune diseases based on current findings.
  • Gutimine and its derivative (T 001) show promise as immunomodulatory agents, warranting further in vivo investigation for autoimmune disorder treatment.